1. Home
  2. JFR vs ATRC Comparison

JFR vs ATRC Comparison

Compare JFR & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Floating Rate Income Fund

JFR

Nuveen Floating Rate Income Fund

HOLD

Current Price

$7.84

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$42.08

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFR
ATRC
Founded
2004
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
JFR
ATRC
Price
$7.84
$42.08
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$52.00
AVG Volume (30 Days)
621.7K
554.8K
Earning Date
01-01-0001
10-29-2025
Dividend Yield
11.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$518,304,999.00
Revenue This Year
N/A
$16.90
Revenue Next Year
N/A
$12.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.80
52 Week Low
$7.61
$28.29
52 Week High
$8.82
$43.11

Technical Indicators

Market Signals
Indicator
JFR
ATRC
Relative Strength Index (RSI) 45.41 70.06
Support Level $7.80 $38.92
Resistance Level $7.96 $42.42
Average True Range (ATR) 0.05 1.67
MACD 0.00 0.63
Stochastic Oscillator 42.50 94.89

Price Performance

Historical Comparison
JFR
ATRC

About JFR Nuveen Floating Rate Income Fund

Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests a majority of its managed assets in secured Senior Loans and unsecured Senior Loans, with an average duration of one year or less, in which unsecured Senior Loans will be, at the time of investment, investment grade quality.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: